The mission of the University of Rochester (UR) Center for AIDS Research (CFAR) is to support a multidisciplinary environment that promotes and enhances HIV/AIDS research at UR, with the goal of improving the prevention, detection and treatment of HIV infection, AIDS and related disease processes. The UR CFAR will achieve this mission by providing the leadership, services and infrastructure necessary to: establish multidisciplinary collaborations that achieve high-impact discoveries;support the early career development of diverse young HIV/AIDS investigators;and to establish a distinctive scientific identity for the Rochester CFAR, placing it at the forefront of HIV/AIDS research. During our funding cycle as a Developmental CFAR (D-CFAR), we have successfully recruited many new investigators into HIV/AIDS research at the UR. As a result, almost two-thirds (63%) of our membership are NIH-defined early stage or new investigators, or investigators new to HIV/AIDS (in roughly equal proportions). We have also developed innovative approaches to program and collaboration building, with the result that the number of HIV/AIDS investigators at UR with R01 or equivalent support has risen by 53% since inception of our D-CFAR, while collaborative research activity (publications and funded grants) have risen by 40% and 56%, respectively. Building on this success, we propose five Aims.
Aim 1 will provide leadership that creates an outstanding scientific environment, and that strategically positions UR at the forefront of HIV/AIDS research.
Aim 2 will stimulate new, innovative research and multidisciplinary collaborations that result in high impact discoveries. It will also establish a unique scientific identity for the UR CFAR in Optics &Imaging Sciences and in RNA Biology.
Aim 3 will identify and mentor the next generation of HIV/AIDS investigators, and Aim 4 will provide an integrated set of scientific Cores that enable cutting-edge HIV research, and that proactively meet investigator needs. Finally, Aim 5 will stimulate communication and engagement with the full range of communities that the UR CFAR serves.

Public Health Relevance

The mission of the University of Rochester (UR) Center for AIDS Research (CFAR) is to support a multidisciplinary environment that promotes and enhances HIV/AIDS research at UR, with the goal of improving the prevention, detection and treatment of HIV infection, AIDS and related disease processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI078498-06
Application #
8489536
Study Section
Special Emphasis Panel (ZAI1-UKS-A (J1))
Program Officer
Beaubien, Candice M
Project Start
2008-05-01
Project End
2018-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
6
Fiscal Year
2013
Total Cost
$1,726,490
Indirect Cost
$551,677
Name
University of Rochester
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Zhang, Gang; Guo, Dongwei; Dash, Prasanta K et al. (2016) The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy. Nanomedicine 12:109-22
Piepenbrink, Michael S; Samuel, Memorie; Zheng, Bo et al. (2016) Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS One 11:e0158641
Fedor, Theresa M; Kohler, Hans-Peter; McMahon, James M (2016) Changing attitudes and beliefs towards a woman's right to protect against HIV risk in Malawi. Cult Health Sex 18:435-52
Nishimura, Christopher; Polesskaya, Oksana; Dewhurst, Stephen et al. (2016) Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation. J Vis Exp :e53582
Makita-Chingombe, Faithful; Kutscher, Hilliard L; DiTursi, Sara L et al. (2016) Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations. J Drug Deliv 2016:3810175
Blanchard, Catlyn; Brooks, Lauren; Ebsworth-Mojica, Katherine et al. (2016) Zinc Pyrithione Improves the Antibacterial Activity of Silver Sulfadiazine Ointment. mSphere 1:
Liu, Bilan; Qiu, Xing; Zhu, Tong et al. (2016) Spatial regression analysis of serial DTI for subject-specific longitudinal changes of neurodegenerative disease. Neuroimage Clin 11:291-301
Yang, Hongmei; Baker, Steven F; González, Mario E et al. (2016) An improved method for estimating antibody titers in microneutralization assay using green fluorescent protein. J Biopharm Stat 26:409-20
Blanchard, Catlyn; Brooks, Lauren; Beckley, Andrew et al. (2016) Neomycin Sulfate Improves the Antimicrobial Activity of Mupirocin-Based Antibacterial Ointments. Antimicrob Agents Chemother 60:862-72
Jones, Letitia D; Jackson, Joseph W; Maggirwar, Sanjay B (2016) Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction. PLoS One 11:e0151702

Showing the most recent 10 out of 128 publications